MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.

Xu X, Jiang X, Chen L, Zhao Y, Huang Z, Zhou H, Shi M

Open source

DOI
10.1089/cbr.2019.2858
Published
2019 Nov
Container
Cancer biotherapy & radiopharmaceuticals
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1089/cbr.2019.2858,
  title = {MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.},
  author = {Xu X and Jiang X and Chen L and Zhao Y and Huang Z and Zhou H and Shi M},
  year = {2019},
  journal = {Cancer biotherapy \& radiopharmaceuticals},
  doi = {10.1089/cbr.2019.2858},
  url = {https://doi.org/10.1089/cbr.2019.2858}
}

RIS

TY  - JOUR
TI  - MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
AU  - Xu X
AU  - Jiang X
AU  - Chen L
AU  - Zhao Y
AU  - Huang Z
AU  - Zhou H
AU  - Shi M
PY  - 2019
JO  - Cancer biotherapy & radiopharmaceuticals
DO  - 10.1089/cbr.2019.2858
UR  - https://doi.org/10.1089/cbr.2019.2858
ER  - 

APA

X, X., X, J., L, C., Y, Z., Z, H., H, Z., & M, S. (2019). MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.. Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1089/cbr.2019.2858

Source records